Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Phospho-PTM proteomic discovery of novel EPO- modulated kinases and phosphatases, including PTPN18 as a positive regulator of EPOR/JAK2 Signaling

Cellular Signalling(2020)10.1016/j.cellsig.2020.109554Source: DataRank Database

Phospho-PTM proteomic discovery of novel EPO- modulated kinases and phosphatases, including PTPN18 as a positive regulator of EPOR/JAK2 Signaling is a research paper published in Cellular Signalling (2020). On theSindex it has a DataRank of 0. It has been cited 14 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access14 citations

Free full text

Cite:

Linked data & code

Data for: The ErythronDB Dataset of the cellular and molecular underpinnings of mammalian erythropoiesis · Dryad

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.45)OA: greenTopics (36)Linked Datasets (1)DataCite Reuse (1)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Emily Greenfest‐Allen ORCID,Su Su ORCID,Christian J. Stoeckert ORCID,Matthew P. Stokes,Don M. Wojchowski ORCID

Live enrichment

PubMed:32027948 OpenAlex:https://openalex.org/W3003293003

National Institutes of Health

Grant: R01 HL044491-21

National Institutes of Health

Grant: 3P20GM113131-05S2

Targeting STAT3 in Ovarian Cancer- Center for Integrated Biomedical and Bioengineering (CIBBR)

National Institutes of Health

Grant: 3P30GM106391-04S1

Phase III COBRE in Stem & Progenitor Cell Biology and Regenerative Medicine

National Institutes of Health

Grant: 5R01HL044491-02

IN VITRO STUDIES OF ERYTHROPOIETIN ACTION

FWCI

0.45

Citation Percentile

0.6%

Citation Trend

2021

2023

2024

2025

2026

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7137739

publisherhttps://api.elsevier.com/content/article/PII:S0898656820300310?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0898656820300310?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.cellsig.2020.109554

Fields of Study

Protein Tyrosine PhosphatasesGalectins and Cancer BiologyPI3K/AKT/mTOR signaling in cancer0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Cell LineErythropoiesisErythropoietinHumansPeptide FragmentsSignal TransductionReceptors, ErythropoietinProteomicsJanus Kinase 2Protein Tyrosine Phosphatases, Non-Receptor

Keywords

Erythropoietin receptorProtein tyrosine phosphataseKinaseCell biologyReceptor tyrosine kinaseSignal transductionJanus kinase 2Tyrosine kinaseBiologyPhosphorylationCancer researchChemistryProteomicsProtein Tyrosine Phosphatases, Non-ReceptorPeptide FragmentsCell LineReceptors, ErythropoietinHumansErythropoiesisErythropoietin

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Data for: The ErythronDB Dataset of the cellular and molecular underpinnings of mammalian erythropoiesis

10.5061/dryad.2bvq83bwqDryad